JUXTAPID
Live / Registered — Registered and renewed (as of 13 Dec 2024)
What this means for you
Registered since 01 Apr 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Apr 2024).
Record
- Serial number
- 85980934
- Registration number
- 4508190
- Mark type
- Stylized text
- Filed
- 14 Dec 2012
- Published for opposition
- 14 May 2013
- Registered
- 01 Apr 2014
- Next maintenance due
- 01 Apr 2024
- Attorney of record
- Richard Todd Armstrong, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA
Owner
- AMRYT PHARMACEUTICALS INC., DUBLIN, DE, US
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
- Aegerion Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 13 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Dec 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 Dec 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2024 — TEAS SECTION 8 & 9 RECEIVED
- 01 Apr 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 May 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 May 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 May 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Mar 2020 — TEAS SECTION 8 & 15 RECEIVED
- 01 Apr 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Apr 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 01 Apr 2014 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED